Cytotoxin and urease activities of Helicobacter pylori isolates from Japanese patients with atrophic gastritis or duodenal ulcer

Journal of Gastroenterology and Hepatology (Australia)

Volumn 11, Issue 9, 1996, Pages 819-824

  Murakita, Hajime ^a   Hirai, Masamichi ^a   Ito, Shigeji ^a   Azuma, Takeshi ^a   Kato, Takuji ^a   Kohli, Yoshihiro ^a   Kuriyama, Masaru ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

Atrophic gastritis; Helicobacter pylori; Urease; Vacuolating cytotoxin

Indexed keywords

CYTOTOXIN; UREASE;

ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; DUODENUM ULCER; FEMALE; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0029847026     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1996.tb00086.x     Document Type: Article

References (43)

1. Warren JR, Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; i: 1273-5.
2. Blaser MJ. Gastric Campylobacter-like organisms, gastritis, and peptic ulcer disease. Gastroenterology 1987; 93: 371-83.
3. Wyatt JI, Dixon MF. Chronic gastritis: A pathogenetic approach. J. Pathol. 1988; 154: 113-24.
4. Kohli Y, Kato T, Iwaki M, Ito S, Suzuki K. Endoscopic diagnosis of Helicobacter pylori distribution in gastric mucosa of patients with chronic gastritis. Eur. J. Gastroenterol. Hepatol. 1993; 5 (Suppl. 1): S127-31.
5. Martin MDF, Montgomery CE, Dobek AS, Patrissi GA, Peura CDA. Campylobacter pylori, NSAIDs, and smoking: Risk factors for peptic ulcer disease. Am. J. Gastroenterol. 1989; 84: 1268-72.
6. Fox G, Correa P, Taylor NS et al. Campylobacter pylori-associated gastritis and immune response in a population at increased risk of gastric carcinoma. Am. J. Gastroenterol. 1989; 84: 775-81.
7. Forman D, Sitas F, Newell DG et al. Geographic association of Helicobacter pylori antibody prevalence and gastric cancer mortality in rural China. Int. J. Cancer 1990; 46: 608-11.
8. Correa P, Fox J, Fontham E et al. Helicobacter pylori and gastric carcinoma: Serum antibody prevalence in populations with contrasting cancer risks. Cancer 1990; 66: 2569-74.
9. Loffeld RJLF, Willems I, Flendrig JA, Arends JW. Helicobacter pylori and gastric carcinoma. Histopathology 1990; 17: 537-41.
10. Parsonnet J, Vandersteen D, Goates J, Sibley RK, Pritikin J, Chang Y. Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas. J. Natl Cancer Inst. 1991; 83: 640-3.
11. Forman D, Newell DG, Fullerton F et al. Association between infection with Helicobacter pylori and risk of gastric cancer: Evidence from a prospective investigation. BMJ 1991; 302: 1302-5.
12. Parsonnet J, Friedman GD, Vandersteen DP et al. Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med. 1991; 325: 1127-31.
13. Nomura A, Stemmermann GN, Chyou P, Kato I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N. Engl. J. Med. 1991; 325: 1132-6.
14. Hentschel E, Brandstatter G, Dragosics B et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N. Engl. J. Med. 1993; 328: 308-12.
15. Hazell SL, Lee A. Campylobacter pyloridis, urease, hydrogen ion back diffusion, and gastric ulcers. Lancet 1986; ii: 15-17.
16. Barer MR, Elliott TSJ, Berkeley D, Thomas JE, Eastham EJ. Cytopathic effects of Campylobacter pylori urease. J. Clin. Pathol. 1988; 41: 597.
17. Xu J, Goodwin CS, Cooper M, Robinson J. Intracellular vacuolization caused by the urease of Helicobacter pylori. J. Infect. Dis. 1990; 161: 1302-1.
18. Leunk RD, Johnson PT, David BC, Kraft WG, Morgan DR. Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J. Med. Microbiol. 1988; 26: 93-9.
19. Figura N, Guglielmetti P, Rossolini A et al. Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only. J. Clin. Microbiol. 1989; 27: 225-6.
20. Cover TL, Dooley CP, Blaser MJ. Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect. Immunity 1990; 58: 603-10.
21. Leunk RD. Production of a cytotoxin by Helicobacter pylori. Rev. Infect. Dis. 1991; 13: S686-9.
22. Cover TL, Blaser MJ. Purification and characterization of the vacuolating toxin from Helicobacter pylori. J. Biol. Chem. 1992; 267: 10570-5.
23. Telford JL, Ghiara P, Dell'Orco M et al. Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J. Exp. Med. 1994; 179: 1653-8.
24. Schmitt W, Haas R. Genetic analysis of the Helicobacter pylori vacuolating cytotoxin: Structural similarities with the IgA protease type of exported protein. Mol. Microbiol. 1994; 12: 307-19.
25. Phadnis SH, Ilver D, Janzon L, Normark S, Westblom TU. Pathological significance and molecular characterization of the vacuolating toxin gene of Helicobacter pylori. Infect. Immunity 1994; 62: 1557-65.
26. Cover TL, Tummuru MK, Cao P, Thompson SA, Blaser MJ. Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J. Biol Chem. 1994; 269: 10 566-73.
27. Crabtree JE, Figura N, Taylor JD, Bugnoli M, Armellini D, Tompkins DS. Expression of 120 kilodalton protein and cytotoxicity in Helicobacter pylori. J. Clin. Pathol. 1992; 45: 733-4.
28. Tummuru MK, Cover TL, Blaser MJ. Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: Evidence of linkage to cytotoxin production. Infect. Immunity 1993; 61: 1799-809.
29. Fox JG, Correa P, Taylor NS et al. High prevalence and persistence of cytotoxin-positive Helicobacter pylori strains in a population with high prevalence of atrophic gastritis. Am. J. Gastroenterol. 1992; 87: 1554-60.
30. Hirai M, Azuma T, Ito S, Kato T. Kohli Y, Fujiki N. High prevalence of neutralizing activity to Helicobacter pylori cytotoxin in serum of gastric-carcinoma patients. Int. J. Cancer 1994; 56: 56-60.
31. Crabtree JE, Wyatt JI, Sobala GM et al. Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut 1993; 34: 1339-43.
32. Cover TL, Puryear W, Perez-Perez GI, Blaser MJ. Effect of urease on HeLa cell vacuolation induced by Helicobacter pylori cytotoxin. Infect. Immunity 1991; 59: 1264-70.
33. Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy 1969; 3: 87-97.
34. Gamou S, Hirai M, Rikimaru K, Enomoto S, Shimizu N. Biosynthesis of the epidermal growth facter receptor in human squamous cell carcinoma lines: Secretion of the truncated receptor is not common to epidermal growth factor receptor-hyperproducing cells. Cell Struct. Funct. 1988; 13: 25-38.
35. Ito S, Kohli Y, Kato T, Abe Y, Ueda T. Significance of ammonia produced by Helicobacter pylori. Eur. J. Gastroenterol. Hepatol. 1994; 6: 167-74.
36. Murakita H, Hirai M, Ito S, Azuma T, Kato T, Kohli Y. Vacuolating cytotoxin production by Helicobacter pylori isolates from peptic ulcer, atrophic gastritis and gastric carcinoma patients. Eur. J. Gastroenterol. Hepatol. 1994; 6 (Suppl. 1): S29-31.
37. Sipponen P, Kekki M, Haapakoski J, Ihamaki T, Siurala M. Gastric cancer risk in chronic atrophic gastritis: Statistical calculation of cross-sectional data. Int. J. Cancer 1985; 35: 173-7.
38. Correa P. A human model of gastric carcinogenesis. Cancer Res. 1988; 48: 3554-60.
39. Correa P. Human gastric carcinogenesis: A multistep and multifocal process. First American cancer society award lecture on cancer epidemiology and prevention. Cancer Res. 1992; 52: 6735-40.
40. Ames BN, Gold JS. Too many rodent carcinogens: Mitogenesis increases mutagenesis. Science 1990; 249: 970-1.
41. Calvert R, Randerson J, Evans P et al. Genetic abnormalities during transition from Helicobacter pylori-associated gastritis to low-grade MALToma. 1995; Lancet 345: 26-7.
42. Suzuki M, Miura S, Suematsu M et al. Helicobacter pylori-associated ammonia production enhances neutrophil-dependent gastric mucosal cell injury. Am. J. Physiol. 1992; 263: G719-25.
43. Marshall BJ, Langton SR. Urea hydrolysis in patients with Campylobacter pyloridis infection. Lancet 1986; i: 965-6.